This narrative review examines the mechanobiology of rotator cuff muscle loss after tendon tear. It asks how altered mechanical loading drives muscle changes at the whole-muscle, fiber, and stem-cell level. The central question: why is muscle loss reversible in early disease but irreversible in advanced disease?
The clinical rule this paper builds toward: match your intervention to the disease stage, because reloading is not universally beneficial. In early atrophic disease, mechanical reloading through exercise or tendon repair can recover muscle. In advanced degenerative disease, the muscle matrix is stiff and fragile, and overload from aggressive rehab may accelerate fiber death.
This reframes fatty infiltration on your Goutallier-staged MRI as more than a marker. It reflects an underlying shift in muscle mechanics and stem cell fate that predicts why massive, retracted tears repair poorly and rarely regain function.
The practical takeaway for surgical decision-making: chronic massive tears with short, non-adapting sarcomeres and a pro-degenerative niche are unlikely to be rescued by tendon repair alone. Keep in mind this is a hypothesis-generating review, and no animal model yet reproduces the human degenerative phenotype, so much of the framework remains to be validated clinically.
This narrative review examines the mechanobiology of rotator cuff muscle loss after tendon tear. It asks how altered mechanical loading drives muscle changes at the whole-muscle, fiber, and stem-cell level. The central question: why is muscle loss reversible in early disease but irreversible in advanced disease?
The clinical rule this paper builds toward: match your intervention to the disease stage, because reloading is not universally beneficial. In early atrophic disease, mechanical reloading through exercise or tendon repair can recover muscle. In advanced degenerative disease, the muscle matrix is stiff and fragile, and overload from aggressive rehab may accelerate fiber death.
This reframes fatty infiltration on your Goutallier-staged MRI as more than a marker. It reflects an underlying shift in muscle mechanics and stem cell fate that predicts why massive, retracted tears repair poorly and rarely regain function.
The practical takeaway for surgical decision-making: chronic massive tears with short, non-adapting sarcomeres and a pro-degenerative niche are unlikely to be rescued by tendon repair alone. Keep in mind this is a hypothesis-generating review, and no animal model yet reproduces the human degenerative phenotype, so much of the framework remains to be validated clinically.